These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2182053)

  • 1. Pharmacology and toxicology of novel drug delivery systems. Regulatory issues.
    Weissinger J
    Drug Saf; 1990; 5 Suppl 1():107-13. PubMed ID: 2182053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
    Shah RR
    Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic relationship.
    Baggot JD
    Ann Rech Vet; 1990; 21 Suppl 1():29S-40S. PubMed ID: 2080844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On setting the first dose in man: quantitating biotherapeutic drug-target binding through pharmacokinetic and pharmacodynamic models.
    Lowe PJ; Tannenbaum S; Wu K; Lloyd P; Sims J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):195-209. PubMed ID: 20050847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated pharmacokinetic and pharmacodynamic approach to controlled drug delivery.
    Breimer DD
    J Drug Target; 1996; 3(6):411-5. PubMed ID: 8863134
    [No Abstract]   [Full Text] [Related]  

  • 7. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug nanocrystals: In vivo performances.
    Gao L; Liu G; Ma J; Wang X; Zhou L; Li X
    J Control Release; 2012 Jun; 160(3):418-30. PubMed ID: 22465393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated pharmacokinetics and pharmacodynamics in drug development.
    Dingemanse J; Appel-Dingemanse S
    Clin Pharmacokinet; 2007; 46(9):713-37. PubMed ID: 17713971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug design.
    Poulin P
    J Pharm Sci; 2015 Jul; 104(7):2359-68. PubMed ID: 25943586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.
    Poulin P; Burczynski FJ; Haddad S
    J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.
    Dostalek M; Akhlaghi F; Puzanovova M
    Clin Pharmacokinet; 2012 Aug; 51(8):481-99. PubMed ID: 22668340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic modeling in vivo.
    Holford NH; Sheiner LB
    Crit Rev Bioeng; 1981; 5(4):273-322. PubMed ID: 7023829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and Pharmacodynamic Principles for Toxicology.
    Lista AD; Sirimaturos M
    Crit Care Clin; 2021 Jul; 37(3):475-486. PubMed ID: 34053701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic characterisation of transdermal delivery systems.
    Berner B; John VA
    Clin Pharmacokinet; 1994 Feb; 26(2):121-34. PubMed ID: 8162656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dosage regimen in controlling indirect pharmacodynamic responses.
    Gobburu JV; Jusko WJ
    Adv Drug Deliv Rev; 2001 Mar; 46(1-3):45-57. PubMed ID: 11259832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chirality on pharmacokinetics and pharmacodynamics.
    Crom WR
    Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S9-14. PubMed ID: 1530005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetic and metabolic studies in the development of drugs].
    Vereczkey L
    Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Challenges and Potential Opportunities for the Pharmaceutical Sciences to Make Global Impact: An FIP Perspective.
    Tucker G; DeSilva B; Dressman J; Ito M; Kumamoto T; Mager D; Mahler HC; Maitland-van der Zee AH; Pauletti GM; Sasaki H; Shah V; Tang D; Ward M
    J Pharm Sci; 2016 Sep; 105(9):2489-2497. PubMed ID: 26886325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.